TerrAscend Reports Preliminary Q2 Revenues Of $72.1 Million
TerrAscend (TSX: TSND) this morning elected to pre-announce preliminary financial results for the second quarter, while scheduling the full results
Read more
TerrAscend Corp
TerrAscend To Begin Trading On The TSX On July 4
TerrAscend (CSE: TER) has “declared its independence” this morning, revealing to the market that it will be the first US
Read more
TerrAscend Moves To Be First TSX-Listed US Cannabis Operator
TerrAscend Corp (CSE: TER) is moving to be one of the first cannabis issuers on the Toronto Stock Exchange with
Read more
Scotts Miracle-Gro Subsidiary Sues TerrAscend’s Jason Wild For Violating Federal Law
The Scotts Miracle-Gro Company (NYSE: SMG) subsidiary Hawthorne has sued cannabis operator TerrAscend Corp (CSE: TER) and its executive chairman
Read more
TerrAscend: Canaccord Initiates Coverage With $4.25 Price Target, Buy Rating
On September 12, Canaccord Genuity initiated coverage on TerrAscend Corp (CSE: TER) with a buy rating and C$4.25 12-month price
Read more
US Cannabis: Stifel Expects “Limited To No Sales Growth”
Earlier this month, Stifel-GMP came out with their US cannabis second quarter preview, calling the bottom on the drawdown but
Read more
TerrAscend Hits US$49.7 Million In Revenue, US$16.0 Million Net Loss In Q1 2022
TerrAscend Corp. (CSE: TER) reported late Thursday its Q1 2022 financial results, which saw the company post US$49.7 million in
Read more
US Cannabis: Stifel Expects Growth To Decelerate In Q4 Earnings
On February 2nd, Stifel-GMP put out their fourth quarter 2021 earnings preview, calling it “The Calm Before the Storm.” They
Read more
TerrAscend: Analyst Consensus Estimates For Q3 2021
TerrAscend Corp (CSE: TER) announced that they will be reporting their third quarter financials before the markets open on November
Read more
Cannabis Companies Have Begun Moving To Self-Insure
There is a common expression in the cannabis industry that “everything is more expensive.” Even in markets where the industry
Read more